×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRDL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
08:44 am
crdl
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis [Yahoo! Finance]
Low
Report
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis [Yahoo! Finance]
12/19
08:30 am
crdl
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
Low
Report
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
12/18
08:07 am
crdl
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/20
11:17 am
crdl
Trends in the $6 Billion Botanical Drugs Industry, 2030: An Assessment of Emerging Growth Opportunities and Strategic Developments [Yahoo! Finance]
Low
Report
Trends in the $6 Billion Botanical Drugs Industry, 2030: An Assessment of Emerging Growth Opportunities and Strategic Developments [Yahoo! Finance]
11/20
08:06 am
crdl
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Medium
Report
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
11/13
08:00 am
crdl
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Medium
Report
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
10/24
08:08 am
crdl
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
10/22
10:56 am
crdl
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Cardiol Therapeutics (CRDL) This Year? [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/18
11:40 am
crdl
Form 6-K Cardiol Therapeutics For: Nov 18
Medium
Report
Form 6-K Cardiol Therapeutics For: Nov 18
11/14
04:52 pm
crdl
Form 6-K Cardiol Therapeutics For: Sep 30
Low
Report
Form 6-K Cardiol Therapeutics For: Sep 30
11/6
03:00 pm
crdl
Form SC 13G/A Cardiol Therapeutics Filed by: MMCAP International Inc. SPC
Low
Report
Form SC 13G/A Cardiol Therapeutics Filed by: MMCAP International Inc. SPC
10/22
06:32 am
crdl
Form 6-K Cardiol Therapeutics For: Oct 22
Medium
Report
Form 6-K Cardiol Therapeutics For: Oct 22
10/11
02:21 pm
crdl
Form 6-K Cardiol Therapeutics For: Oct 11
Low
Report
Form 6-K Cardiol Therapeutics For: Oct 11
10/10
03:15 pm
crdl
Form 6-K Cardiol Therapeutics For: Oct 10
Low
Report
Form 6-K Cardiol Therapeutics For: Oct 10
10/9
04:27 pm
crdl
Form SUPPL Cardiol Therapeutics
Low
Report
Form SUPPL Cardiol Therapeutics
10/9
02:17 pm
crdl
Form 6-K Cardiol Therapeutics For: Oct 09
Medium
Report
Form 6-K Cardiol Therapeutics For: Oct 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: